Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
MRNA | Moderna, Inc. | -6.45% | 171.14 | 0.0% | $784.22m | |
AMGN | Amgen, Inc. | 0.43% | 248.36 | 1.5% | $592.28m | |
VRTX | Vertex Pharmaceuticals, Inc. | 1.66% | 298.83 | 1.9% | $438.24m | |
GILD | Gilead Sciences, Inc. | 0.65% | 62.00 | 1.0% | $379.78m | |
REGN | Regeneron Pharmaceuticals, Inc. | -1.35% | 622.15 | 2.6% | $351.29m | |
NVAX | Novavax, Inc. | -29.64% | 40.28 | 75.7% | $335.10m | |
SNSS | Sunesis Pharmaceuticals, Inc. | -12.15% | 3.47 | 0.7% | $242.57m | |
ILMN | Illumina, Inc. | -3.67% | 214.80 | 3.3% | $229.68m | |
BIIB | Biogen, Inc. | 0.01% | 217.59 | 1.8% | $197.59m | |
BNTX | BioNTech SE | -7.14% | 157.21 | 0.0% | $155.97m | |
GOVX | GeoVax Labs, Inc. | -0.35% | 2.86 | 0.0% | $145.88m | |
CRSP | CRISPR Therapeutics AG | -7.69% | 75.13 | 0.6% | $117.81m | |
PLRX | Pliant Therapeutics, Inc. | 11.19% | 21.16 | 0.0% | $108.38m | |
RYTM | Rhythm Pharmaceuticals, Inc. | 7.19% | 22.65 | 0.0% | $105.42m | |
BMRN | BioMarin Pharmaceutical, Inc. | 0.00% | 95.70 | 4.2% | $98.26m |
Company Profile
Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.